Table 3.

Regression analysis for association between fracture site, time since fracture, and number of fractures with PROs in patients with fractures (n  =  185)^a.

Variable	Coefficient (95% CI)
			OPAQ-SV
	EQ-5D	EQ-VAS	Physical	Emotional	Symptom
Days since fracture	0.0000	−0.0021	0.0017	0.0016	0.0007
	(−0.00003, 0.00004)	(−0.0018, 0.0060)	(−0.0019, 0.0052)	(−0.0016, 0.0048)	(−0.0036, 0.0050)
	p = .895	p = .285	p = .363	p = .319	p = .752
Fracture siteb
Hip (n  =  29)	−0.110	−8.6285	−13.834	−12.561	−15.274
	(−0.1947, −0.0253)	(−16.4079, −0.8491)	(−21.1488, −6.5184)	(−17.9830, −7.1384)	(−23.3411, −7.2076)
	p = .011	p = .030	p < .001	p<.001	p<.001
Spine (n  =  71)	−0.129	−11.454	−13.205	−11.765	−17.131
	(−0.1937, −0.0644)	(−18.0936, −4.8151)	(−18.2881, −8.1209)	(−16.7712, −6.7583)	(−24.0758, −10.1868)
	p<.001	p = .001	p<.001	p<.001	p<.001
Rib (n  =  10)	0.004	−7.935	−1.422	−0.881	−6.495
	(−0.0851, 0.0930)	(−17.8313, −1.9604)	(−10.8690, 8.0241)	(−9.9859, 8.2233)	(−17.4503, 4.4605)
	p = .930	p = .115	p = .766	p = .848	p = .243
Humerus (n  =  3)	−0.040	−4.702	−11.060	−5.761	−8.914
	(−0.1209, 0.0411)	(−9.9148, 0.5102)	(−31.0558, 8.9356)	(−14.4575, 2.9356)	(−16.2919, −1.5364)
	p = .331	p = .077	p = .275	p = .192	p = .018
Other (n  =  27)	−0.044	−10.756	−7.660	−12.619	−12.666
	(−0.1310, 0.0433)	(−20.8036, −0.7080)	(−14.8730, −0.4470)	(−20.4102, −4.8284)	(−22.6770, −2.6559)
	p = .321	p = .036	p = .038	p = .002	p = .014
Number of fractures	−0.021	−5.751	−0.663	−1.930	−2.278
	(−0.0588, 0.0167)	(−10.4627, −1.0391)	(−4.1802, 2.8540)	(−4.7582, 0.8978)	(−6.2619, 1.7068)
	p = .272	p = .017	p = .709	p = .179	p = .260

Abbreviations. CI, confidence interval; EQ-5D, European Quality of Life 5 Domains; EQ-VAS, European Quality of Life Visual Analog Scale; OPAQ-SV, Osteoporosis Assessment Questionnaire short-version.

^aModel included number of fractures, fracture site, and days since fracture only. p-values were adjusted to account for physician clustering.

^bReference fracture site was the wrist.